These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28093879)

  • 41. Hyperammonemia and valproic acid-induced encephalopathy.
    Modjtahedi B; Xiong GL
    Am J Psychiatry; 2007 Dec; 164(12):1912-3; author reply 1913-4. PubMed ID: 18056251
    [No Abstract]   [Full Text] [Related]  

  • 42. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case with hyperammonemic encephalopathy triggered by single dose valproate.
    Ciftci S; Guler A; Deveci E; Celebisoy N; Yuceyar N
    Neurol Sci; 2016 Dec; 37(12):2017-2018. PubMed ID: 27436290
    [No Abstract]   [Full Text] [Related]  

  • 44. Unilateral basal-ganglia involvement likely due to valproate-induced hyperammonemic encephalopathy.
    Joardar S; Das S; Chatterjee R; Guha G; Hasmi MA
    Neurol Sci; 2012 Aug; 33(4):919-22. PubMed ID: 22086613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 47. Valproate-induced hyperammonemic encephalopathy.
    Verrotti A; Trotta D; Morgese G; Chiarelli F
    Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Valproic Acid and hypersensitivity syndrome.
    Roepke S; Treudler R; Anghelescu I; Orfanos CE; Tebbe B
    Am J Psychiatry; 2004 Mar; 161(3):579. PubMed ID: 14992991
    [No Abstract]   [Full Text] [Related]  

  • 49. Sodium valproate-related hyperammonaemic encephalopathy.
    Pegg EJ; Zaman F
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24722719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].
    Mattei A; Bernard G; Plauchu G; Paliard P
    Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949
    [No Abstract]   [Full Text] [Related]  

  • 51. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.
    Barrueto F; Hack JB
    Acad Emerg Med; 2001 Oct; 8(10):999-1001. PubMed ID: 11581089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.
    Lokrantz CM; Eriksson B; Rosén I; Asztely F
    Acta Neurol Scand; 2004 Apr; 109(4):297-301. PubMed ID: 15016014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Valproate-induced hyperammonemic encephalopathy].
    Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
    Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report.
    Mehta S; Tayabali S; Lachmann R
    J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carnitine supplementation for valproate-related hyperammonemia to maintain therapeutic valproate level.
    Sonik P; Hilty DM; Rossaro L; Bourgeois JA
    J Clin Psychopharmacol; 2011 Oct; 31(5):680-2. PubMed ID: 21881462
    [No Abstract]   [Full Text] [Related]  

  • 58. Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy.
    Schwarz S; Georgiadis D; Schwab S; Gehlen F; Mayatepek E; Zoubaa S
    J Neurol Neurosurg Psychiatry; 2002 Jul; 73(1):90-1. PubMed ID: 12082063
    [No Abstract]   [Full Text] [Related]  

  • 59. A case of delirium and subsequent pancytopenia associated with the oral loading of valproic acid.
    Chae BJ; Kang BJ
    J Clin Psychiatry; 2005 Jun; 66(6):801-2. PubMed ID: 15960580
    [No Abstract]   [Full Text] [Related]  

  • 60. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.